Company · CIK 0001510487
Principia Biopharma Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/APrincipia Biopharma Inc.0000929638-21-000373 · 122.7 KBSEC(opens sec.gov)
- SC 13D/APrincipia Biopharma Inc.0001387131-20-008670 · 48.6 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-20-255598 · 285.5 KBSEC(opens sec.gov)
- SC 13G/APrincipia Biopharma Inc.0000315066-20-001730 · 8.4 KBSEC(opens sec.gov)
- SC 13DPrincipia Biopharma Inc.0000921895-20-002317 · 375.0 KBSEC(opens sec.gov)
- SC 13GPrincipia Biopharma Inc.0000921895-20-002285 · 291.2 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-20-221651 · 802.8 KBSEC(opens sec.gov)
- 10-QQuarterly update0001564590-20-037804 · 8.7 MBSEC(opens sec.gov)
- 8-KCurrent report0001564590-20-037763 · 390.9 KBSEC(opens sec.gov)
- 8-KCurrent report0001564590-20-030809 · 203.6 KBSEC(opens sec.gov)
Insiders
- AKKARAJU SRINIVASDirector
- Babler MartinDirector, President, CEO
- Baker Bros. Advisors (GP) LLC10% Owner
- BAKER BROS. ADVISORS LP10% Owner
- BAKER FELIX10% Owner
- BAKER JULIAN10% Owner
- Becker Daniel J.Director
- BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
- Biotechnology Value Trading Fund OS LPSee Explanation of Responses
- BVF GP HOLDINGS LLC10% Owner
Tickers
No tickers on record.
Addresses
business
220 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA, 94080
mailing
220 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA, 94080
Same industry